Clinical Trials · NCT01604057

Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass

Name: Study to Evaluate Effect of Intranasal Teriparatide on Serum P1NP, a Biomarker of Bone Formation, in Postmenopausal Women With Low Bone Mass
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

UnknownPhase 2Teriparatide

Phase: Phase 2
Recruitment status: Unknown
Sponsor: Azelon Pharmaceuticals
Enrollment: 130
Start date: Nov 2011
Locations: See registry
Primary endpoint: Change in Serum P1NP from baseline to end of treatment.

View Teriparatide compound reference